Acurx Pharmaceuticals, Inc. (ACXP)
2.08
-0.01
(-0.48%)
USD |
NASDAQ |
May 07, 15:43
Acurx Pharmaceuticals SG&A Expense (TTM) : 6.230M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Apyx Medical Corp. | 22.11M |
| Quince Therapeutics, Inc. | 15.05M |
| Lantern Pharma, Inc. | 6.464M |
| Sensei Biotherapeutics, Inc. | 9.056M |
| Vivos Therapeutics, Inc. | 29.13M |